XPH

SPDR S&P Pharmaceuticals ETF [XPH] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

XPH Stock Summary

Top 10 Correlated ETFs

XPH


Top 10 Correlated Stocks

XPH


In the News

12:46 29 Nov 2023 XPH

Pharma ETFs in Focus Post Q3 Earnings

Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.

07:32 29 Nov 2023 XPH

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Care ETFs category of the market.

07:31 29 Nov 2023 XPH

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.

01:47 29 Nov 2023 XPH

Pharma ETFs in Focus Post Q2 Earnings

Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.

02:27 29 Nov 2023 XPH

Cautious on Big Tech & AI? Try These Value-Focused Sector ETFs

Value-focused investing comes to rescue if high-growth sectors fail for some reasons.

07:34 29 Nov 2023 XPH

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Care ETFs category of the market.

10:24 29 Nov 2023 XPH

XPH: Non-Diversified U.S.-Based Large-Cap Pharma ETF Isn't Very Attractive

XPH's consistent low yield and poor price growth (mostly negative) over both short-run as well as over long-run should be disheartening for investors. Expiration of a large number of patents within 2030, and narrow revenue stream expected from orphan drugs will impact the pharmaceutical industry. Revlimid, Januvia/Janumet, Reyvow, Bedaquiline, Keytruda, Opdivo, Eliquis, Ibrance, Stelara, Trulicity - all drugs are going to become off-patent by 2030.

08:03 29 Nov 2023 XPH

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the SPDR S&P Pharmaceuticals ETF (XPH), a passively managed exchange traded fund launched on 06/19/2006.

07:40 29 Nov 2023 XPH

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Launched on 06/19/2006, the SPDR S&P Pharmaceuticals ETF (XPH) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.

01:01 29 Nov 2023 XPH

Pharma ETFs Gain Post Q1 Earnings

Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.

XPH Financial details

Company Rating
-
Market Cap
204.11M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.14
Dividend %
1.51%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
1.49%
SMA50
-14.01%
SMA100
-9.76%
Inst Own
50.74%
Inst Trans
1.38%
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
5.5M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
34.67-44.31
52W High
-16.73%
52W Low
+7.76%
RSI
47.67
Rel Volume
0.93
Avg Volume
46.07K
Volume
42.89K
Perf Week
1.27%
Perf Month
-4.48%
Perf Quarter
-10.63%
Perf Half Y
-6.29%
-
-
-
-
Beta
0.67
-
-
Volatility
0.18%, 0.69%
Prev Close
-0.68%
Price
36.64
Change
-1.21%

XPH Financial Performance

XPH Frequently Asked Questions

What is SPDR S&P Pharmaceuticals ETF stock symbol ?

SPDR S&P Pharmaceuticals ETF is a US stock and trading under the symbol XPH

What is SPDR S&P Pharmaceuticals ETF stock quote today ?

SPDR S&P Pharmaceuticals ETF stock price is $36.64 today.

Is SPDR S&P Pharmaceuticals ETF stock public?

Yes, SPDR S&P Pharmaceuticals ETF is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap